GIANNITRAPANI, Lydia
 Distribuzione geografica
Continente #
NA - Nord America 14.587
EU - Europa 12.997
AS - Asia 6.964
SA - Sud America 986
AF - Africa 233
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 13
Totale 35.811
Nazione #
US - Stati Uniti d'America 14.306
IT - Italia 6.108
SG - Singapore 2.432
RU - Federazione Russa 2.254
CN - Cina 1.759
FI - Finlandia 991
HK - Hong Kong 872
BR - Brasile 763
DE - Germania 741
UA - Ucraina 666
VN - Vietnam 647
PL - Polonia 429
FR - Francia 375
GB - Regno Unito 351
IE - Irlanda 329
BD - Bangladesh 237
JP - Giappone 235
NL - Olanda 180
SE - Svezia 163
IN - India 160
CA - Canada 131
KR - Corea 103
RO - Romania 93
TR - Turchia 81
BE - Belgio 78
AR - Argentina 73
MX - Messico 62
IQ - Iraq 58
ES - Italia 49
CI - Costa d'Avorio 47
AT - Austria 44
PK - Pakistan 42
ZA - Sudafrica 42
IR - Iran 41
UZ - Uzbekistan 34
ID - Indonesia 32
MA - Marocco 32
VE - Venezuela 32
EG - Egitto 28
CL - Cile 26
CO - Colombia 26
AU - Australia 25
PH - Filippine 25
CH - Svizzera 24
EC - Ecuador 24
DZ - Algeria 23
NP - Nepal 23
AE - Emirati Arabi Uniti 20
AZ - Azerbaigian 20
MY - Malesia 20
TN - Tunisia 19
CZ - Repubblica Ceca 18
JM - Giamaica 17
KZ - Kazakistan 17
SA - Arabia Saudita 17
CR - Costa Rica 15
GR - Grecia 15
PE - Perù 15
AL - Albania 14
JO - Giordania 14
LB - Libano 14
LT - Lituania 14
KE - Kenya 13
PY - Paraguay 11
RS - Serbia 11
HN - Honduras 10
BG - Bulgaria 9
SV - El Salvador 9
DO - Repubblica Dominicana 7
ET - Etiopia 7
EU - Europa 7
UY - Uruguay 7
AM - Armenia 6
IL - Israele 6
NZ - Nuova Zelanda 6
PA - Panama 6
PS - Palestinian Territory 6
PT - Portogallo 6
BH - Bahrain 5
BO - Bolivia 5
GT - Guatemala 5
KG - Kirghizistan 5
NI - Nicaragua 5
SN - Senegal 5
BY - Bielorussia 4
DK - Danimarca 4
GE - Georgia 4
HU - Ungheria 4
KH - Cambogia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
EE - Estonia 3
HR - Croazia 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
MN - Mongolia 3
MT - Malta 3
NO - Norvegia 3
OM - Oman 3
Totale 35.757
Città #
Ashburn 1.814
Singapore 1.617
Fairfield 1.239
Chandler 999
San Jose 932
Woodbridge 663
Hong Kong 643
Houston 618
Wilmington 605
Ann Arbor 518
Seattle 489
Milan 456
Palermo 407
Cambridge 406
Moscow 375
Zgierz 360
Jacksonville 341
Dublin 325
Rome 311
Beijing 289
Des Moines 273
New York 266
Medford 253
Los Angeles 250
Tokyo 227
Santa Clara 222
Ho Chi Minh City 216
Council Bluffs 213
Dallas 199
Frankfurt am Main 196
Nanjing 187
Princeton 168
The Dalles 168
Naples 160
Hanoi 155
Lauterbourg 152
Boardman 149
Altamura 143
Dearborn 107
Tulsa 98
Lawrence 97
Helsinki 96
San Diego 92
Hefei 89
Buffalo 85
Florence 76
São Paulo 75
Shenyang 73
Chicago 72
Brussels 70
Orem 68
Hebei 65
Jinan 63
Turin 63
Venice 63
Nanchang 61
Verona 59
Falls Church 58
Tianjin 57
Bologna 55
Changsha 55
Munich 53
London 50
Nuremberg 49
Abidjan 47
Ludwigshafen am Rhein 45
Denver 43
Brooklyn 42
Ningbo 42
Da Nang 41
Jiaxing 41
Catania 40
Warsaw 39
Genoa 38
Phoenix 38
Cagliari 36
Chennai 36
Columbus 36
Toronto 35
Amsterdam 34
Bari 34
Hangzhou 34
Atlanta 33
Zhengzhou 33
Brescia 31
Montreal 31
Campinas 29
Rio de Janeiro 29
Izmir 28
Guangzhou 27
Napoli 27
Padova 27
Redwood City 26
Johannesburg 25
Perugia 25
Cardiff 24
Kumar 24
Manchester 24
Paris 24
Salerno 24
Totale 20.045
Nome #
Nodulo epatico ipovascolare: ruolo dell’ecografia nella diagnosi di HCC 4.275
MODIFICAZIONI ECOGRAFICHE DELLA LINFADENOPATIA DELL’ILO EPATICO DOPO ERADICAZIONE DELL’HCV CON DIRECT-ACTING ANTIVIRALS 554
PRESENTAZIONE ECOGRAFICA DELL’EPATOCARCINOMA: ESPERIENZA DI UN SINGOLO CENTRO NELL’ARCO DI TRE DECENNI 411
A phenobarbital overdose: a case report 402
Clinical manifestations and outcome predictors of SARS-COV2 disease (COVID-19): experience of a single center. 395
ALLELIC VARIANTS OF CYP2E1 GENE IN HEPATOCARCINOMA PATIENTS AND IN HEPATIC TUMOR CELL LINES 392
Clinical course and management of acute and chronic viral hepatitis during pregnancy. 303
Ruolo dell'interazione NK/KIR nella storia naturale delle infezioni virali 302
Hepatocellular carcinoma: Comparison of two different periods at the same center 282
Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review 276
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. 276
EFFETTI DELLA TERAPIA CON DIRECT ACTING ANTIVIRALS (DAAS) SUI PARAMETRI ECOGRAFICI DI IPERTENSIONE PORTALE 264
An unusual Erdheim-Chester disease with orbital involvement: A case report 262
Surveillance program for diagnosis of hcc in liver cirrhosis: Role of ultrasound echo patterns 262
Hemophagocytic syndrome in a patient with disseminated tuberculosis: A case report 261
A key role for abdominal ultrasound examination in "difficult" diagnoses of celiac disease 257
Low-grade fever: how to distinguish organic from non-organic forms. 256
Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects 249
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study 248
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 245
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 244
Associated Factors and Liver Disease Severity for Decreased Bone Mineral Density in HIV Mono- and HIV/HCV Co-infected Patients 242
The health of irregular and illegal immigrants: analysis of day-hospital admissions in a department of migration medicine 241
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 240
Nontumorous portal vein thrombosis in liver cirrhosis: Possible role of β-blockers 240
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 236
Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia. 234
Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection 232
Association Between Single Nucleotide Polymorphisms in the Cyclooxygenase-2, Tumor Necrosis Factor-a, and Vascular Endothelial Growth Factor-A Genes, and Susceptibility to Hepatocellular Carcinoma 231
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases 231
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. 230
Genetic determined down regulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer 229
The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center 226
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods 221
Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. 220
The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population 217
Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. 216
Sex hormones and risk of liver tumor 215
Abdominal US evaluation in celiac disease before and after a gluten-free diet 214
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 212
Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid 212
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 209
Interessamento epatico in corso di febbre bottonosa del Mediterraneo 209
Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study 207
Affidabilità del bright liver nella steatosi epatica in soggetti con ipertransaminasemia criptogenetica e con epatopatia da virus C 205
Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons 205
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 205
Case report: acute portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent adult 204
Epidemiology, Diagnosis, and Non-Pharmacological Treatment of HCC 203
Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment 202
PREVALENCE OF LIVER DISEASES IN A POPULATION OF IMMIGRANTS IN SICILY. ANALYSIS OF DAY-HOSPITAL ADMISSIONS IN A DEPARTMENT OF MIGRATION MEDICINE 201
Il bright liver echopattern come strumento diagnostico non invasivo di steatosi nell'ipertransaminasemia criptogenetica 200
Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C. 199
Association between single nucleotide polymorphisms (SNPs) of IL-6, TNF-alpha and VEGF-A genes, and susceptibility to hepatocellular carcinoma (HCC) 198
Circulating levels of molecular adhesion correlate with stage of renal disease and C-reactive protein in chronic kidney disease 197
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 197
Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI 196
Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report. 195
Osteoporosis risk factors in HIV positive women with osteoporosis: A retrospective analysis 195
COMEPA (COVID-19 Medicina Policlinico Palermo): a study in hospitalized patients. 195
Late-onset Sheehan's syndrome presenting with rhabdomyolysis and hyponatremia: a case report. 194
Cyclooxygenase- 2, Tumor Necrosis Factor-α, Vascular Endothelial Growth Factor-A and IL-6 genes SNPs and IL-6 serum levels in liver cirrhosis and hepatocellular carcinoma 194
Hepatic expression of cyclooxygenase-2 in non alcoholic fatty liver disease 193
Association between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample 192
IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. 191
Affidabilità del Bright liver echopattern nella diagnosi di steatosi in pazienti con ipertransaminasemia criptogenetica 190
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 188
Minor hepatic resection for hepatocellular carcinoma in cirrhotic patients: Kelly clamp crushing resection versus heat coagulative necrosis with bipolar radiofrequency device 188
Optimizing diagnostic approach to drug-induced liver injury 188
SCREENING DELL’EPATOCARCINOMA (HCC) NELLA CIRROSI EPATICA (CE): RUOLO DEI PATTERN ECOGRAFICI (US) 187
Alteraziioni morfofunzionali vascolari in una popolazione con sindrome metabolica e steatosi epatica ecografica 186
A questionable diagnosis in a woman with drowsiness 186
IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma 185
Drammaturgia di un prurito 184
HepaDisk – A new quality of life questionnaire for HCV patients 184
Two single nucleotide polymorphisms in the MICA gene and sMICA plasma levels are associated with hepatocellular carcinoma development in an Italian population of HCV related liver cirrhosis 181
Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results. 181
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 179
Variable Number of Tandem Repeats (VNTR) gene polymorphism of CYP2E1 in patients with pancreatic adenocarcinoma 179
SURVEILLANCE PROGRAM FOR DIAGNOSIS OF HCC IN LIVER CIRRHOSIS: ROLE OF ULTRASOUND ECHOPATTERNS 178
Affidabilità del bright liver nella diagnosi di steatosi epatica in pazienti con infezione da virus dell'immunodeficienza acquisita (HIV), da virus dell'epatite C (HCV) e coinfezione HCV/HIV: dati preliminari 176
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 176
Common polymorphisms in Th1 and Th2 cytokine genes and susceptibility to pancreatic adenocarcinoma 175
CEUS in the differential diagnosis between biliary sludge, benign lesions and malignant lesions 175
Genetic determined downregulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer 173
Effects of direct-acting antiviral therapy (DAAS) on the ultrasound parameters of portal hypertension 173
Waiting-time and quality of care deserved to patients with early stage hepatocellular carcinoma undergoing RFA treatment 172
Non invasive tools for the diagnosis of liver cirrhosis 171
New landscapes and horizons in hepatocellular carcinoma therapy 171
Long-term follow-up of hepatitis C virus-positive patients with persistently normal serum transaminases 169
NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response 169
Himpact of liver steatosis on the antiviral response in the hepatitis C virus –associated chronic hepatitis. 167
Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease 165
null 164
VEGFR-2, HSP90 and GRP78/BiP expression and HCC recurrence after Liver Transplantation 164
Disfunzione endoteliale e malattia carotidea in pazienti con bright liver echopattern 163
Distribution of liver disease in a cohort of immigrants in Sicily: analysis of day-hospital admissions in a migration medicine unit 163
Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis 163
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 159
Association between single nucleotide polymorphisms in the COX-2, TNF-alpha and VEGF-A genes and susceptibility to hepatocellular carcinoma 158
Totale 25.871
Categoria #
all - tutte 109.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.279


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.200 109 383 81 95 102 137 91 125 285 288 127 377
2022/20233.663 327 476 80 332 306 454 262 526 358 84 232 226
2023/20243.280 169 338 218 293 244 414 277 221 100 395 249 362
2024/20254.674 219 376 294 477 300 220 365 285 336 442 582 778
2025/202612.527 890 336 647 924 1.174 1.829 1.750 1.280 1.004 1.513 536 644
2026/2027316 316 0 0 0 0 0 0 0 0 0 0 0
Totale 36.637